Publications by authors named "Tyler Halladay"

Claim this Profile
A
Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safety.
Yan-Ruide Li, Yichen Zhu, Zhe Li, Xinyuan Shen, Tyler Halladay

Mol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo CAR engineering for immunotherapy.
Yan-Ruide Li, Yichen Zhu, Tyler Halladay, Lili Yang

Nat Rev Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells.
Yan-Ruide Li, Junhui Hu, Zhe Li, Enbo Zhu, Yuning Chen, Tyler Halladay

Cell Rep Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture.
Yan-Ruide Li, Kuangyi Zhou, Derek Lee, Yichen Zhu, Tyler Halladay

Nat Protoc· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breaking the mold: Unconventional T cells in cancer therapy.
Yan-Ruide Li, Kuangyi Zhou, Yichen Zhu, Tyler Halladay, Lili Yang

Cancer Cell· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies.
Yan-Ruide Li, Tyler Halladay, Lili Yang

J Biomed Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis